Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update

B STATEN ISLAND, N.Y., May 12, 2026 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new…
posteditor
posteditor
Articles: 17424

Other News